Skip to content
Screener

LeMaitre Vascular LMAT Q2 2025 earnings

Reported August 5, 2025 · After market close

Revenue$64.2MBeat by $3.3M
EPS$0.60Beat by $0.03
Revenue estimate$60.9M
EPS estimate$0.57

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.4M
EPS estimate$0.69

Financials

Q2 2025

Income statement

See full
Revenue$64.2M+15.0%
Gross profit$45.0M+16.9%
Operating income$16.1M+12.3%
Net income$13.8M+16.5%
EPS (diluted)$0.60+15.4%

Balance sheet

See full
Cash & equivalents$27.2M+22.0%
Total debt$17.7M-3.9%
Total equity$362.7M+13.5%
Total assets$577.6M+59.1%

Cash flow

See full
Operating cash flow$20.3M+111%
CapEx$1.3M-28.5%
Free cash flow$18.9M+145%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.92B+4.1%
Enterprise value$1.91B+3.8%
P/E40.7×-8.2×
P/S8.2×-0.8×

Profitability

See full
Gross margin69.1%+1.4pp
Operating margin23.3%+1.1pp
Net margin20.1%+1.8pp
FCF margin22.3%+6.9pp

Returns & leverage

See full
Return on equity13.8%+1.3pp
Debt / equity0×0.0×
Current ratio14×+5.6×

Segments

By geography

See full
US$36.7M—
DE$4.5M—
CA$4.0M—
GB$3.3M—

FAQ

When did LeMaitre Vascular report Q2 2025 earnings?
LeMaitre Vascular (LMAT) reported Q2 2025 earnings on August 5, 2025 after market close.
What were LeMaitre Vascular's Q2 2025 revenue and EPS?
LeMaitre Vascular reported revenue of $64.2M and eps of $0.60 for Q2 2025.
Did LeMaitre Vascular beat estimates in Q2 2025?
Revenue beat the consensus estimate of $60.9M by $3.3M. EPS beat the consensus estimate of $0.57 by $0.03.
How did LeMaitre Vascular's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.0% from $55.8M a year earlier and eps grew 15.4% from $0.52.
Where can I find LeMaitre Vascular's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-024862) and the 10-Q periodic report (0001437749-25-024936) directly on SEC EDGAR. The filing index links above go to sec.gov.